Abstract
Bipolar disorder (BD) is a cyclical and chronic affective disorder, globally recognized as an important public health problem and characterized by mood changes with recurring phases such as mania and depression. It is considered a complex disease, depending on the interaction of genetic and environmental triggers (stressors factors), but with a poorly known pathogenesis. Recent studies have implicated immune factors in the pathogenesis of BD and more particularly associated with different human major histocompatibility complex (MHC) regions. A major consortium study have recently linked BD to hundreds of variations with stronger associations in the MHC region, such as the rs3130297 SNP, located in the NOTCH4 gene, with an additional overlapping association with schizophrenia. This short review focuses on studies that investigated the association between bipolar disorder and the MHC, and the involvement of the immune system in the pathogenesis of the disease, in order to provide further information for additional diagnostic and therapeutic strategies. Fully understanding the etiology and pathophysiology of BD is extremely important to define new approaches for intervention and prevention, maybe through the modulation of the immune system.
Similar content being viewed by others
References
Balakumar P, Singh M (2006) Anti-tumor necrosis factor-α therapy in heart failure: future directions. Pharmacol Toxicol 99:391–397
Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315–329
Brietzke E, Kapczinski F (2008) TNF-α as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1355–1361
Choi KH, Higgs BW, Wendland JR, Song J, McMahon FJ, Webster MJ (2011) Gene Expression and Genetic Variation Data Implicate PCLO in Bipolar Disorder. Biol Psychiatry 69:353–359
Clerici M, Arosio B, Mundo E et al (2009) Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr 14:419–425
Czerski PM, Rybakowski F, Kapelski P, Rybakowski JK, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A (2008) Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology 57:88–94
Drexhage RC, Knijff EM, Padmos RC et al (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar dirsorder. Expert Ver Neurother 10:59–76
Fertuzinhos SMM, Oliveira JRM, Nishimura AL et al (2004) Analysis of IL-1α, IL-1 β, and IL-RA Polymorphisms in Dysthymia. J Mol Neurosci 22:251–256
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 70:1078–1090
Gomez JA, Majumder P, Nagarajan UM, Boss JM (2005) X box-like sequences in the MHC class II region maintain regulatory function. J Immunol 175:1030–1040
Guloksuz S, Cetin EA, Cetin T, Deniz G, Oral ET, Nutt DJ (2010) Cytokine levels in euthymic bipolar patients. J Affect Disord 126:458–462
Irwin M, Miller A (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:374–383
Johnson GF (1978) HLA antigens and manic–depressive disorders. Biol Psychiatry 13:409–412
Jun TY, Pae CU, Chae JH, Pyo CW, Han H (2002) Human leukocyte antigen alleles in patients with bipolar disorder in the Korean population. Psychiatry Clin Neurosci 56:453–457
Kakiuchi C, Iwamoto K, Ishiwata M et al (2003) Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35:171–175
Kaminsky Z, Tochigi M, Jia P. et al (2011) A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol Psychiatry
Kim Y, Jung H, Mynt A, Kim H, Park S (2007) Imbalance between proinflammatory cytokines in bipolar disorder. J Affect Disord 104:91–95
Kronfol Z, Remick D (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–94
Lechler R, Warrens A (2000) HLA in Health and Disease, 2nd edn. Academic press, London
Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234–239
Licinio J, Frost P (2000) The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics. Braz J Med Res 33:1141–1148
Lie BA, Thorsby E (2005) Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol 17:529
Machado-Vieira R, Kapczinski F, Soares JC (2004) Perspectives for the Development of New Animal Models of Bipolar Disorder. Prog Neuropshychopharmacol Biol Psychiatry 28:209–224
Matsuzaka Y, Makino S, Nakajima K et al (2001) New polymorphic microsatellite markers in the human MHC class III region. Tissue Antigens 57:397–404
Modrego PJ, Ferrández J (2000) Familial multiple sclerosis with repetitive relapses of manic psychosis in two patients (mother and daughter). Behav Neurol 12:175–179
Moskvina V, Craddock N, Holmans P et al (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14:252–260
Müller-Oerlinghausen B, Berghöfer A, Bauer M (2002) Bipolar Disorder. Lancet 359:241–247
Nakatani N, Hattori E, Ohnishi T et al (2006) Genome-wide expression analysis detects eight gene with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet 15:1949–1962
Nery FG, Monkul ES, Hatch JP et al (2008) Celecoxib as na adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a doubleblind, randomized, placebo-controlled study. Hum Psychopharmacol 23:87–94
O'Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90:263–267
Ozcan ME, Taskin R, Banoglu R, Babacan M, Tuncer E (1996) HLA antigens in schizophrenia and mood disorders. Biol Psychiatry 39:891–895
Schloesser R, Huang J, Klein P, Manji H (2008) Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33:100–133
Shapiro RW, Bock E, Rafaelsen OJ, Ryder LP, Svejgaard A (1976) Histocompatibility antigens and manic-depressive disorders. Arch Gen Psychiatry 33:823–825
Shapiro RW, Ryder LP, Svejgaard A, Rafaelsen OJ (1977) HLA antigens and manic-depressive disorders: further evidence of na association. Psychol Med 7:387–396
Shi J, Levinson DF, Duan J et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757
Shiina T, Hosomichi K, Inoko H, Kulski JK (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54:15–39
Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the hypothalamicpituitary- adrenal (HPA) axis during viral infection. Viral Immunol 18:41–78
Steiner J, Bielau H, Brisch R et al (2008) Immunilogical aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatry Res 42:151–157
Swift-Scanlan T, Lan TH, Fallin MD et al (2002) Genetic analysis of the (CTG)n NOTCH4 polymorphism in 65 multiplex bipolar pedigrees. Psychiatr Genet 12:43–47
Targum SD, Gershon ES, Van Eerdewegh M, Rogentine N (1979) Human leukocyte antigen system not closely linked to or associated with bipolar manic–depressive illness. Biol Psychiatry 14:615–636
The International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P (2009) Common polygenic variation contributes to risk of schizophrenia that overlaps with bipolar disorder. Nature 460:748–752
Ucok A, Akar U, Polat A, Yazici O (2005) Human leukocyte antigen alleles in patients with bipolar disorder in Turkey. Eur Psychiatry 20:83
Vandiedonck C, Knight CJ (2009) The human major histocompatibility complex as a paradigm in genomics research. Brief Funct Genomics Proteomics 8:379–394
Vandiedonck C, Beaurain G, Giraud M et al (2004) Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci 101:15464–15469
Ventura T, Lobo A, Marco JC (1990) HLA antigens in bipolar affective patients. Actas Luso Esp Neurol Psiquiatric Cienc Afines 18:339–343
Wei J, Hemmings GP (2000) The NOTCH4 locus is associated with susceptibility to schizophrenia. Nature Genet 25:376–377
Wentzel J, Roberts DF, Whalley LJ (1982) HLA in manic–depressive psychosis. Psychol Med 12:275–278
Williams HJ, Craddock N, Hamshere ML et al (2011) Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boumdaries. Hum Mol Genet 20:387–391
Yolken RH, Torrey EF (1995) Viruses, Schizophrenia and Bipolar Disorder. Clin Microbiol Rev 8:131–145
Acknowledgments
This study received financial support from the following Brazilian funding agencies and academic bureaus: LIKA-UFPE, PROPESQ-UFPE, and CAPES.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Figueiredo, T.C., de Oliveira, J.R.M. Reconsidering the Association Between the Major Histocompatibility Complex and Bipolar Disorder. J Mol Neurosci 47, 26–30 (2012). https://doi.org/10.1007/s12031-011-9656-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9656-6